Jinxin Fertility Group Limited
Research Jinxin Fertility Group Limited (1951.HK) on Bullrun: market cap HKD 5.52B, P/E 27.4, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1951.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyHKD
- Market capHKD 5.52B
- P/E27.4
- Dividend yield1.9%
- Financial periodFY2025
- RevenueCNY 2.65B
- Revenue growth-5.8%
- Net income-CNY 976.15M
- Free cash flowCNY 324.44M
- Gross margin33.5%
Valuation Snapshot
latest market cap is HKD 5.52B; P/E is 27.4; dividend yield is 1.9%.
Peer valuation comparison
Latest P/E is 27.44x versus a Healthcare sector median of 21.69x (26.5% above).
Latest dividend yield is 1.87% versus a Healthcare sector median of 2.41% (22.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 2.65B | -CNY 976.15M | CNY 324.44M | 33.5% | -0.36 | CNY 905.78M | CNY 2.85B | CNY 9.14B |
| FY2024 | CNY 2.81B | CNY 283.10M | CNY 366.84M | 39.1% | 0.1 | CNY 546.20M | CNY 2.60B | CNY 10.27B |
| FY2023 | CNY 2.79B | CNY 344.72M | CNY 510.92M | 42.1% | 0.12 | CNY 624.28M | CNY 2.55B | CNY 10.09B |
| FY2022 | CNY 2.36B | CNY 121.12M | -CNY 417.65M | 37.0% | 0.05 | CNY 1.32B | CNY 4.16B | CNY 8.64B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 5.52B | 27.4 | 1.9% | 0.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.04 HKD, yield 1.9%.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.06 CNY |
| FY2022 | 0.07 CNY |
About Jinxin Fertility Group Limited
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and internationally. The company provides two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jinxin Fertility Group Limited's market cap?
Jinxin Fertility Group Limited's market capitalization is HKD 5.52B.
What is Jinxin Fertility Group Limited's P/E ratio?
Jinxin Fertility Group Limited's price-to-earnings (P/E) ratio is 27.4.
Does Jinxin Fertility Group Limited pay a dividend?
Jinxin Fertility Group Limited has a dividend yield of 1.9%.
What does Jinxin Fertility Group Limited do?
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and internationally. The company provides two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.